WallStreetZenWallStreetZen

NASDAQ: RPTX
Repare Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their RPTX stock forecasts and price targets.

Forecast return on equity

Is RPTX forecast to generate an efficient return?

Company
-38.74%
Industry
96.01%
Market
-62.4%
RPTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RPTX forecast to generate an efficient return on assets?

Company
-33.65%
Industry
36.03%
RPTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RPTX earnings per share forecast

What is RPTX's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.11

RPTX revenue forecast

What is RPTX's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$20.0M+1,763.93%
Avg 2 year Forecast
$20.0M+1,763.93%
RPTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RPTX revenue growth forecast

How is RPTX forecast to perform vs Biotechnology companies and vs the US market?

Company
160.68%
Industry
90.71%
Market
11.87%
RPTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RPTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RPTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RPTX$1.88N/AN/A
IMUX$0.84$7.00+737.32%Strong Buy
CLNN$8.16$33.00+304.41%Strong Buy
ACET$0.99$6.00+506.67%Strong Buy
DTIL$7.16$60.00+737.99%Buy
View Top Biotech Stocks

Repare Therapeutics Stock Forecast FAQ

What is RPTX's earnings growth forecast for 2025-2025?

(NASDAQ: RPTX) Repare Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 4.08%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.96%.

Repare Therapeutics's earnings in 2025 is -$127,894,000.

In 2025, RPTX is forecast to generate -$90,500,860 in earnings, with the lowest earnings forecast at -$90,500,860 and the highest earnings forecast at -$90,500,860.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.

What is RPTX's revenue growth forecast for 2025-2026?

(NASDAQ: RPTX) Repare Therapeutics's forecast annual revenue growth rate of 160.68% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 90.71%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.87%.

Repare Therapeutics's revenue in 2025 is $1,073,000.On average, 1 Wall Street analysts forecast RPTX's revenue for 2025 to be $857,828,060, with the lowest RPTX revenue forecast at $857,828,060, and the highest RPTX revenue forecast at $857,828,060.

In 2026, RPTX is forecast to generate $857,828,060 in revenue, with the lowest revenue forecast at $857,828,060 and the highest revenue forecast at $857,828,060.

What is RPTX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: RPTX) forecast ROA is -33.65%, which is lower than the forecast US Biotechnology industry average of 36.03%.

What is RPTX's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: RPTX) Repare Therapeutics's current Earnings Per Share (EPS) is -$3.02. In 2025, RPTX's EPS is forecast to hit -$2.11 (min: -$2.11, max: -$2.11).

What is RPTX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: RPTX) forecast ROE is -38.74%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.